Contraindications - DePuy Mitek GII QUICKANCHOR Plus Handbuch

implantation studies of PANACRYL braided
absorbable suture in animals indicate that
approximately 80% of its original strength
remains 3 months after implantation. At
6 months post-implantation, approximately
60% of its original strength is retained.*
OR
2. ETHIBOND
non-absorbable suture.
OR
3. ORTHOCORD
sterile, braided, composite suture composed
of dyed (D&C Violet #2 or D&C Blue #6)
absorbable polydiaxanone (PDS) and un-dyed
non-absorbable polyethylene. The partially
absorbable suture is coated with a copolymer
of 90% caprolactone and 10% glycolide.
The PDS copolymer has been shown to be
nonantigenic, nonpyrogenic and elicits only
a slight tissue reaction during absorption.
Needles: Surgical stainless steel, see package
label for type and size.

CONTRAINDICATIONS

1. Reattachment of intracapsular knee ligaments
(ACL & PCL).
2. Surgical procedures other than those listed in
the INDICATIONS section.
3. Pathologic conditions of bone, such as
cystic changes or severe osteopenia, which
would impair its ability to securely fix the
DePuy Mitek Anchor are contraindicated.
4. Pathological changes in the soft
tissues sutured to the bone which would
prevent its secure fixation by the suture
are contraindicated.
5. Comminuted bone surface, which would
militate against secure fixation of the
DePuy Mitek Anchor, is contraindicated.
6. Physical conditions that would eliminate or
tend to eliminate adequate implant support
or retard healing, i.e., blood supply limitation,
previous infections, are contraindicated.
7. Conditions which tend to preempt the
patient's ability or the healing period, such
as senility, mental illness or alcoholism
are contraindicated.
8. The DePuy Mitek Anchor is not designed for
and should never be used to attach artificial
ligaments or other implants.
‚ braided polyester,
®
Suture is a synthetic,
®
3